Emerging Echinocandin Resistance – A Review
P. Sneka, Mahalakshmi Krishnan, V. Sangamithra
Journal of Pharmaceutical Research International · pp. 60–66 · Published 3 Dec 2021
10.9734/jpri/2021/v33i53A33639Abstract
Worldwide there is a steady increase in the number of fungal infections each year. Simultaneously, there is a high rise of antifungal resistance among the Candida isolates. This has now become a major concern in hospitalized patients resulting in poor treatment outcome. Echinocandins, a new group of antifungals has given promising results inspite of its increasing rate of resistance exhibited by some Candida species.
Cited by 0
No indexed citations yet.
Related research
- Candida Bloodstream Infection and Antifungal Susceptibility Over Three Years in a Single Center from Medinah, Saudi Arabia — shares topic coverage
- Detection of Mutated erg11 and fks1 Genes among Resistant Candida Species Isolated in Pregnant Women in Mbarara, Uganda — shares topic coverage
- Disseminated Histoplasmosis in an Immunocompetent Patient from a Non Endemic Region, North India: Pointers to Potential Endemicity — shares topic coverage
- Pathogenesis of Candida Auris: A Threat Emerging during Corona Pandemic — shares topic coverage
- Mucormycosis and It’s Prevalence in the Patients of COVID-19 — shares topic coverage
Article metrics
Real usage data collected on this platform.
4
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.